🔎 Trials Near Me

Hjem › KOL › Michigan

KOL kliniske forsøg i Michigan

22 studier for KOL søger deltagere på steder i Michigan.

Byer i Michigan

Officiel studietekst (engelsk)

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Ann Arbor
  • Research Site, Flint
  • Research Site, Southfield
  • og 1 flere
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Vitalis Clinical Research Center- Site Number : 8400040, Allen Park
  • Bolt Clinical Research- Site Number : 8400086, Brighton
  • Henry Ford Hospital- Site Number : 8400058, Detroit
  • og 1 flere
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222

WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

  • University of Michigan Medical Center, Ann Arbor
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07558265

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Revive Research Institute, Inc., Southfield
RekruttererFase 2
Alder 40 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • University of Michigan Health System - Ann Arbor- Site Number : 8400090, Ann Arbor
  • Veritas Clinical Research- Site Number : 8400007, Madison Heights
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  • Henry Ford Hospital, Detroit
Rekrutterer
Alder 40 til 80 · Alle køn · Opdateret 17. sep. 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Farmington Hills
  • Research Site, Garden City
  • Research Site, Grand Rapids
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • University of Michigan, Ann Arbor
  • Henry Ford Health, Detroit
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Ann Arbor
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Farmington Hills
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Revival Research Institute, LLC, Dearborn
  • AA Medical Research Center, Flint
  • Revive Research Institute, Inc., Southfield
  • og 1 flere
RekruttererFase 2/3
Alder 35 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT07363694

Multi-Center Clean Air Randomized Controlled Trial in COPD

  • University of Michigan, Ann Arbor
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06376994

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Allen Park
  • GSK Investigational Site, Clarkston
  • GSK Investigational Site, Dearborn
RekruttererFase 3
Alder 40 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07177339

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

  • John D. Dingell VA Medical Center, Detroit, MI, Detroit
Rekrutterer
Alder 60 og opefter · Alle køn · Opdateret 5. jun. 2026 · NCT04179981

SPIROMICS Study of Early COPD Progression (SOURCE)

  • University of Michigan, Ann Arbor
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 30 til 55 · Alle køn · Opdateret 3. jun. 2026 · NCT05033990

Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • John D. Dingell VA Medical Center, Detroit, MI, Detroit
Rekrutterer
Alder 60 til 89 · Alle køn · Opdateret 26. maj 2026 · NCT02703207

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

  • Henry Ford Hospital - Lung and Pulmonary Care, Detroit
Rekrutterer
Alder 40 til 80 · Alle køn · Opdateret 28. apr. 2026 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

  • University of Michigan, Ann Arbor
Rekrutterer
Alder 40 til 84 · Alle køn · Opdateret 24. apr. 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Allen Park
  • GSK Investigational Site, Detroit
  • GSK Investigational Site, Garden City
  • og 1 flere
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 9. apr. 2026 · NCT06961214

University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2

  • University of Michigan, Ann Arbor
RekruttererObservationsstudie
Alder 50 til 80 · Alle køn · Opdateret 25. mar. 2026 · NCT07482475

Supporting Evidence-based Responses to Emotional Needs in Emphysema

  • Henry Ford Health System, Detroit
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 30. jan. 2026 · NCT06600126

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • Henry Ford Health, Detroit
Rekrutterer
Alder 30 og opefter · Alle køn · Opdateret 6. feb. 2025 · NCT05204888

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.